{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:45:28Z","timestamp":1761176728815,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.tracli.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T18:06:57Z","timestamp":1216058817000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pourquoi ajourner au don de sang des candidats au motif d\u2019un risque de maladie de Chagas\u00a0?"],"prefix":"10.1016","volume":"15","author":[{"given":"O.","family":"Garraud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0958-7578.2004.00513.x","article-title":"The European Blood Directive: a new era of blood regulation has begun","volume":"14","author":"Faber","year":"2004","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-3148.2006.00697.x","article-title":"Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening","volume":"16","author":"McDonald","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood.V90.9.3776","article-title":"Natural history of GBV-C\/hepatitis G virus (HGV) infection through the follow-up of GBV-C\/HGV-infected blood donors and recipients studied by RNA PCR and anti-E2 serology","volume":"90","author":"Lefrere","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2008.05.003_bib4","first-page":"129","article-title":"Parasites et transfusion sanguine\u00a0: causes et cons\u00e9quences","volume":"12","author":"El Ghouzzi","year":"2006","journal-title":"Hematologie (Paris)"},{"key":"10.1016\/j.tracli.2008.05.003_bib5","first-page":"2209","article-title":"Trypanosomiases","volume":"56","author":"Pelloux","year":"2006","journal-title":"Rev Prat"},{"key":"10.1016\/j.tracli.2008.05.003_bib6","unstructured":"http:\/\/www.paho.org\/english\/hcp\/hct\/dch\/chagas.htm. (Consult\u00e9 en septembre 2007)."},{"key":"10.1016\/j.tracli.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1751-2824.2007.00052.x","article-title":"The globalization of Chagas disease","volume":"2","author":"Schmunis","year":"2007","journal-title":"ISBT Science Series"},{"key":"10.1016\/j.tracli.2008.05.003_bib8","first-page":"285","article-title":"Diagnosis, management and treatment of chronic Chagas\u2019 disease in areas where Trypanosoma cruzi infection is not endemic","volume":"60","author":"Gascon","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.tracli.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of human Chagas disease","volume":"1","author":"Prata","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tracli.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/511859","article-title":"Zoonoses in solid-organ and hematopoietic stem cell transplant recipients","volume":"44","author":"Kotton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tracli.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10995-007-0246-8","article-title":"Mother-to-child transmission of Chagas\u2019 disease in North America: Why don\u2019t we do more?","volume":"12","author":"Buekens","year":"2007","journal-title":"Matern Child Health"},{"key":"10.1016\/j.tracli.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0036-46652002000200008","article-title":"Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection","volume":"44","author":"Camandaroba","year":"2002","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.tracli.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3083.2007.01968.x","article-title":"Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishement: Can we strike first?","volume":"66","author":"Acosta Rodriguez","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.tracli.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/pgmj.2006.047357","article-title":"Chagas disease","volume":"8","author":"Teixeira","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.tracli.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/08916930410001713115","article-title":"Innate and acquired immunity in the pathogenesis of Chagas disease","volume":"37","author":"Golgher","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tracli.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1741-6892.2004.00467.x","article-title":"Threats to blood safety posed by emerging protozoan pathogens","volume":"87s2","author":"Leiby","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2008.05.003_bib17","first-page":"S83","article-title":"The clinical benefits of the leukoreduction of blood products","volume":"60","author":"Blajchman","year":"2006","journal-title":"J Trauma"},{"key":"10.1016\/j.tracli.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1999.60.205","article-title":"Chagas\u2019 disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods","volume":"60","author":"Gomes","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tracli.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1590\/S0074-02762004000800001","article-title":"Update on Chagas disease in Venezuela \u2013 a review","volume":"99","author":"Anez","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.tracli.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-3156.2007.01831.x","article-title":"Exposure to mixed asymptomatic infections with Trypanosoma cruzi, Leishmania braziliensis and Leishmania chagasi in the human population of the greater Amazon","volume":"12","author":"Mendes","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.tracli.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.1060638","article-title":"Modeling household transmission of American trypanosomiasis","volume":"293","author":"Cohen","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tracli.2008.05.003_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1099\/jmm.0.46149-0","article-title":"Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay","volume":"55","author":"Malan","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tracli.2008.05.003_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S0031182004005785","article-title":"Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area","volume":"12","author":"Gutierrez","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.tracli.2008.05.003_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-3148.2006.00703.x","article-title":"Field evaluation of four novel enzyme immunoassays for Chagas\u2019 disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains","volume":"16","author":"Berrizbeitia","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2008.05.003_bib25","unstructured":"World Health Organisation. Control of Chagas disease. Second report of the WHO Expert Committee, 2002, Geneva. Technical Reports Series No. 905."},{"key":"10.1016\/j.tracli.2008.05.003_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tracli.2006.11.005","article-title":"Mechanisms of transfusion-linked parasite infection","volume":"13","author":"Garraud","year":"2006","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2008.05.003_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5858\/2007-131-719-PITDSF","article-title":"Pathogen inactivation: the definitive safeguard for the blood supply","volume":"131","author":"Bryant","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tracli.2008.05.003_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1503\/cmaj.070882","article-title":"Canadian Blood Services to screen for Chagas disease","volume":"177","author":"Comeau","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.tracli.2008.05.003_bib29","unstructured":"Centers for Disease Control and Prevention (CDC). Blood donor screening for chagas disease \u2013 United States, 2006\u20132007. MMWR Morb Mortal Wkly Rep 2007;56:141\u20133."},{"key":"10.1016\/j.tracli.2008.05.003_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1471-4922(03)00139-9","article-title":"Class and subclass selection in parasite-specific antibody responses","volume":"19","author":"Garraud","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.tracli.2008.05.003_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.0041-1132.2005.04214.x","article-title":"The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region","volume":"45","author":"Pirard","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2008.05.003_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1423-0410.2004.00571.x","article-title":"Chagas\u2019 disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank","volume":"87","author":"Silveira-Lacerda","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2008.05.003_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1423-0410.2003.00340.x","article-title":"Chagas\u2019 disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test","volume":"85","author":"Gadelha","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2008.05.003_bib34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.medmal.2007.09.001","article-title":"Diagnostic du paludisme d\u2019importation en France","volume":"37","author":"De Pina","year":"2007","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.tracli.2008.05.003_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1537-2995.2006.01147.x","article-title":"Transfusion-acquired Trypanosoma cruzi infection","volume":"47","author":"Young","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2008.05.003_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199910143411615","article-title":"Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion","volume":"341","author":"Leiby","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2008.05.003_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tmaid.2006.01.010","article-title":"Measures to prevent transfusion-associated protozoal infections in non-endemic countries","volume":"5","author":"Garraud","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tracli.2008.05.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tracli.2004.12.001","article-title":"European strategies against the parasite transfusion risk","volume":"12","author":"Reesink","year":"2005","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2008.05.003_bib39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1590\/S0074-02762004000800004","article-title":"Seroprevalence of Trypanosoma cruzi infection in French Guiana","volume":"99","author":"Aznar","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"S1","key":"10.1016\/j.tracli.2008.05.003_bib40","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/01.aids.0000255091.29050.13","article-title":"Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study","volume":"21","author":"Bouillon","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.tracli.2008.05.003_bib41","first-page":"587","article-title":"Comparaison de techniques de d\u00e9pistages d\u2019anticorps anti-paludiques utilis\u00e9es en transfusion","volume":"63","author":"Soler","year":"2003","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.tracli.2008.05.003_bib42","unstructured":"Jeannel D, Pillonel J. Maladie de Chagas\u00a0: estimation du risque transfusionnel li\u00e9 aux donneurs avec une exposition potentielle \u00e0 Trypanosoma cruzi. InVS, 2007."},{"key":"10.1016\/j.tracli.2008.05.003_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.patbio.2007.06.008","article-title":"Maladie de Chagas\u00a0: \u00e9valuation des tests de d\u00e9pistage dans un centre de transfusion des arm\u00e9es","volume":"55","author":"Kerleguer","year":"2007","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.tracli.2008.05.003_bib44","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/j.1537-2995.2006.01010.x","article-title":"Managing threats rather than risks in blood transfusion: robust design for a complex system","volume":"46","author":"Murphy","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2008.05.003_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.seminhematol.2006.09.016","article-title":"Emerging infectious diseases that threaten the blood supply","volume":"44","author":"Alter","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tracli.2008.05.003_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/S0037-86822005000100022","article-title":"International meeting on surveillance and prevention of the Chagas disease in the Amazonia: implementation of intergovernment initiative, Manaus, State of Amazon, 19\u201322 September 2004","volume":"38","author":"Rojas","year":"2005","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.tracli.2008.05.003_bib47","first-page":"495","article-title":"Pathogen reduction technology: methods, status of clinical trials, and future prospects","volume":"2","author":"Corash","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.tracli.2008.05.003_bib48","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1086\/527448","article-title":"Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor","volume":"46","author":"Flores-Ch\u00e1vez","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782008000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782008000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:29:46Z","timestamp":1761128986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782008000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1246782008000992"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2008.05.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pourquoi ajourner au don de sang des candidats au motif d\u2019un risque de maladie de Chagas\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}